Cargando…
Juvenile Myelomonocytic Leukemia: Molecular Pathogenesis Informs Current Approaches to Therapy and Hematopoietic Cell Transplantation
Juvenile myelomonocytic leukemia (JMML) is a rare childhood leukemia that has historically been very difficult to confidently diagnose and treat. The majority of patients ultimately require allogeneic hematopoietic cell transplantation (HCT) for cure. Recent advances in the understanding of the path...
Autores principales: | Dvorak, Christopher C., Loh, Mignon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975112/ https://www.ncbi.nlm.nih.gov/pubmed/24734223 http://dx.doi.org/10.3389/fped.2014.00025 |
Ejemplares similares
-
Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment
por: Wintering, Astrid, et al.
Publicado: (2021) -
Case Report: Juvenile Myelomonocytic Leukemia Underlying Ornithine Transcarbamylase Deficiency Safely Treated Using Hematopoietic Stem Cell Transplantation
por: Eguchi, Hiroi, et al.
Publicado: (2022) -
Parvovirus B19 Infection Mimicking Juvenile Myelomonocytic Leukemia in an Immunocompetent Child
por: Mathew, Aji, et al.
Publicado: (2020) -
Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021) -
Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia
por: Hecht, Anna, et al.
Publicado: (2020)